About me
With over 25 years of experience in pharmaceutical R&D, Luman is a regulatory nonclinical expert specializing in small molecules, biologics, cell and gene therapies, and medical devices. A primary author of over 20 INDs and 5 NDAs/BLAs, Luman has led regulatory strategies, nonclinical GAP analyses, and program development across oncology, cardiovascular, infectious disease, and neuropharmacology. As an executive consultant at Management Consultants, Luman provides strategic nonclinical regulatory guidance to top pharmaceutical firms, leveraging extensive experience in regulatory submissions, compliance auditing, and global regulatory authority engagements to drive successful drug development and approvals.
